Sponsor Pipeline

Artiva Biotherapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06991114 AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in… Refractory Rheumatoid Arthritis (RA) Recruiting
Phase 1
NCT06265220 AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for… Lupus Nephritis - WHO Class III Active, Not Recruiting
Disease Areas
Lupus (SLE) (1) Rheumatoid Arthritis (1) Scleroderma (1)
Get alerts when Artiva Biotherapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free